Afrezza / hexametric combinations and Technosphere

[jpg]

Thinking outside the box maybe...

I don't know if this is technically possible with Technosphere tech but combining monomeric and hexametric insulin could be an elegant tailoring of insulin profiles for individual needs.

An innovative BP (do they even exist?) could basically build a whole new paradigm (and franchise that would leave the competition in the dust for a generation) of ultra rapid to rapid to medium term insulins around Technosphere?

I wonder if this has ever been considered by Mannkind's scientists (and Al Mann of coarse)? Not something for now but for the next 20 years. Could be a powerful selling point to a partnership?

Thoughts?


JPG

[liane]

jpg,

It certainly crossed my mind...

[jpg]

It would be an elegant solution to progression of diabetic (type2) disease. You start off with 100% monomeric (Afrezza) and with time blend in some hexametric insulin. You keep the peak advantages of monomeric inhaled insulin and extend the tail as needed.
Again it would take a far seeing BP who gets science. Oddly enough they are in short supply right now it seems. There are a few well run BP out there though. I hope someone will see this opportunity. Might be worth mentioning it to Deerfield and Greenhill!

JPG